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Abstract: In this communication we review selected experiments involving the use of 
carbon paste electrodes (CPEs) to monitor and measure brain tissue O2 levels in awake 
freely-moving animals. Simultaneous measurements of rCBF were performed using the H2 
clearance technique. Voltammetric techniques used include both differential pulse (O2) and 
constant potential amperometry (rCBF). Mild hypoxia and hyperoxia produced rapid 
changes (decrease and increase respectively) in the in vivo O2 signal. Neuronal activation 
(tail pinch and stimulated grooming) produced similar increases in both O2 and rCBF 
indicating that CPE O2 currents provide an index of increases in rCBF when such increases 
exceed O2 utilization. Saline injection produced a transient increase in the O2 signal while 
chloral hydrate produced slower more long-lasting changes that accompanied the behavioral 
changes associated with anaesthesia. Acetazolamide increased O2 levels through an increase 
in rCBF. 
Keywords: In-vivo voltammetry; cerebral blood flow; hypoxia and hyperoxia; neuronal 
activation; chloral hydrate anaesthesia; acetazolamide 
 
Introduction 
Molecular O2 was one of the first substances detected voltammetrically in vivo, both in brain 
[1,2] and peripheral tissues [3], using noble metal and carbon electrodes that continue to be the 
electrode materials of choice for this analyte [4-7]. Brain tissue O2 is one of the most important 
substrate for energy metabolism delivered by the blood and responds to a range of perturbations 
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including electrical stimulation [8] and neuromediator release [9], with more rapid turnover in cerebral 
cortex compared with other brain areas [10]. The tissue concentration is determined by the balance 
between supply and utilization and the anatomical distribution of concentrations reported within the 
brain is wide, depending on the depth of penetration of the sensor into the tissue [11] and the 
heterogeneity of the tissue [12,13]. The spread of mean concentrations reported ranges from 40 µM 
[12], through 50 µM [10] and 60 µM [14], to 80 µM [8,15].  
The majority of such measurements have generally been obtained amperometrically using 
constant potential amperometry (CPA) at a noble metal microelectrode where the measured current is 
taken to be proportional to the dissolved O2 [16].  The use of carbon-based electrodes as cathodes for 
O2 reduction, instead of the more commonly used Pt, has recently been reported by several groups [17-
20]. Carbon electrodes have the advantage that they are less prone to surface poisoning and as such do 
not require the use of protecting membranes which are a characteristic of metal-based O2 electrodes, 
including the most commonly used Clark electrode.  Carbon electrodes are also more stable and in the 
case of carbon paste electodes (CPEs) have been found to be stable over several months in vivo [21].  
Recently, a new method for the measurement of dissolved O2 in vivo involving Nafion™-modified 
carbon fibre disk electrodes (CFEs) and fast cyclic voltammetry has been reported by Wightman’s 
group [18,20,22]. As a fast-scan technique this method also has advantages associated with subsecond 
time resolution.  However, because of the small dimensions of CFEs (typically 10 µm) the 
concentration of O2 observed varies depending on the orientation of the electrode relative to the blood 
vessels and metabolically active sites.  Since the dimension (typically 125-µm active internal diameter) 
of CPEs is greater than the scale of a capillary zone (< 100 µm) [23], an average tissue O2 level should 
be detected, thus offering a practical advantage over the use of CFEs for O2 measurements. In this 
communication we present a review of selected experiments involving the use of CPEs to successfully 
monitor and measure brain tissue O2 levels in awake freely-moving animals.  
 
Experimental 
 
Reagents 
 
The acetazolamide (Diamox) and chloral hydrate were obtained from Sigma Chemical Co. 
(Dorset, UK) and BDH Laboratory Supplies (Poole, UK) respectively. Solutions of normal saline (0.5 
mL, 0.9% NaCl), chloral hydrate (350 mg/kg), and Diamox (50 mg/kg) were administered 
intraperitoneally (i.p.). All solutions were prepared using doubly distilled deionised water. 
 
Working Electrode Preparation 
 
CPEs were made from 5T (125-µm bare diameter, 160-µm coated diameter) Teflon-coated 
silver wire (Advent Research Materials, Suffolk, UK). The Teflon insulation was slid along the wire to 
create an approximately 2-mm deep cavity which was packed with carbon paste using a bare silver 
wire as plunger. Carbon paste was prepared by thoroughly mixing 2.83 g of carbon powder  (UCP-1-M, 
Ultra Carbon Corp., Bay City, MI, USA) and 1.0 mL of silicone oil (Aldrich, Catalogue No. 17,563-3) 
[24]. The H2 detection electrodes for rCBF measurements (see Voltammetric Techniques) were made 
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from 2T (50-µm bare diameter, 75-µm coated diameter) Teflon-coated Pt/Ir wire as reported 
previously [25]. All electrodes were soldered to gold connectors, which were cemented into a six-pin 
plastic socket (both from Plastics One, Roanoke, VA, USA). 
 
Voltammetric Techniques 
 
Changes in O2 at CPEs were monitored using differential pulse amperometry (DPA). For DPA 
O2 reduction, two equally sized cathodic pulses were applied, the first from a resting potential at -150 
mV to -350 mV that corresponds to the foot of the reduction wave for O2 at lipid-modified CPEs, and 
the second from -350 mV to -550 mV that corresponds to the peak of the reduction wave. The 
difference in the current (∆I) sampled during these respective pulse pairs was calculated, and changes 
in ∆I used as a measure of changes in O2 that have been shown to be interference free [19]. Because 
the CPE DPA signal has a significant capacitance (background) current (mean value: -244.8 ± 59.7 nA, 
n = 23) [26] changes in the signal cannot be calculated as a percentage [25].  
The CPEs were calibrated for O2 in vitro after removal from the brain because implantation 
affects the sensitivity of these paste electrodes [27,28]. All in vitro experiments were carried out in a 
standard three-electrode glass electrochemical cell (capacity 25 mL) in phosphate buffered saline (PBS) 
solution (20 mL), pH 7.4 (150 mM NaCl, 40 mM NaH2PO4 and 40 mM NaOH). A saturated calomel 
electrode (SCE) was used as the reference electrode, and a large silver wire, isolated in a compartment 
containing PBS, served as the auxiliary electrode. Calibrations were performed in N2-purged, air-
saturated and O2-saturated solutions where the concentrations of solution O2 were taken as 0, 200 
[29,30] and 1,250 µM [29], respectively. 
Measurements of rCBF were performed using the H2 clearance technique. CPA, where the 
detecting electrode is held at a constant potential sufficient to detect the oxidation or reduction of the 
target substance, was performed by holding the CPE at the peak potential for H2 oxidation (+250 mV). 
The methods of H2 administration and analysis used in these experiments have been described in detail 
in a previous publication [25]. 
 
Surgical Procedures 
 
Male Sprague-Dawley rats weighing 200-300 g were anaesthetized, following published 
guidelines [31], with a mixture of Hypnorm (Fentanyl citrate/Fluanisone, Janssen Pharmaceuticals Ltd., 
Oxford, UK), Hypnovel (Midazolam, Roche Products Ltd., Herts, UK), and sterile water, mixed 1:1:2 
and injected i.p. at a volume of 3.3 mL/kg, as described previously [32,33]. Once surgical anesthesia 
was established animals were placed in a stereotaxic frame and the electrodes implanted following a 
previously described procedure [32]. Animals were implanted with either one of two combinations of 
sensors: (i) carbon paste electrodes, for monitoring tissue O2, one in the right and one in the left 
striatum (coordinates with the skull leveled between bregma and lambda, were: A/P +1.0 from bregma, 
M/L ±2.5, and D/V -5.0 from dura [32]; (ii) a 2T Pt/Ir electrode, for monitoring rCBF by the H2 
clearance method, was implanted in the right striatum (coordinates: A/P +1.0 from bregma, M/L +2.5, 
and D/V -8.5 from dura), and a carbon paste electrode, for monitoring tissue O2, in the left striatum 
(coordinates: A/P +1.0 from bregma, M/L -2.5, and D/V -5.0 from dura). A reference electrode (8T Ag 
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wire, 200-µm bare diameter; Advent Research Materials) was placed in the cortex, an auxiliary 
electrode (8T Ag wire) placed between the skull and dura, and an earth wire (8T Ag wire) attached to 
one of the support screws. The reference potential provided by the Ag wire in brain tissue is very 
similar to that of the SCE [27]. The electrodes and probe were fixed to the skull with dental screws and 
dental acrylate (Associated Dental Products Ltd., Swindon, UK). Surgery typically lasted 40 min and 
anesthesia was reversed by an i.p. injection of naloxone (0.1 mg/kg, Sigma Chemical Co.). Post-
operative analgesia was provided in the form of a single injection (0.1 mg/kg, s.c.) of Vetergesic 
(Buprenorphine hydrochloride, Reckitt and Colman Pharmaceuticals, Hull, UK) given immediately 
following the surgery. Animals were allowed to recover after surgery and were assessed for good 
health according to published guidelines [34] immediately after recovery from anesthesia and at the 
beginning of each day. This work was carried out under license in accordance with the Animals 
(Scientific Procedures) Act, 1986. 
 
Experimental Conditions 
 
Rats were housed in large plastic bowls (diameter ca. 50 cm), in a windowless room under a 12 
h light, 12 h dark cycle, lights coming on at 8 a.m., with free access to water.  Food was available ad 
libitum. All experiments were carried out with the animal in its home bowl. Implanted electrodes were 
connected to the potentiostat at least 60 min prior to the start of each experiment, through a six-pin 
Teflon socket, and a flexible screened six core cable which was mounted through a swivel above the 
rat’s head (Semat Technical Ltd.). This arrangement allowed free movement of the animal. Once the 
background currents for the various sensors had stabilized (typically 5-10 min for the O2 CPEs, and 30 
min for the rCBF Pt/Ir electrodes) experiments were begun. All signals were recorded at 2-s intervals 
(see Instrumentation and Software).  
Mild hypoxia and hyperoxia were produced by the administration of O2/air and N2/air mixtures; 
plastic tubing, connected to the respective gas cylinder (British Oxygen Co. (BOC), Guildford, UK) 
was held ca. 2-3 cm from the animal’s snout for 3-min periods. A flow rate of ca. 150 mL/min was 
used. This procedure resulted in the inhalation of an air/gas mixture. 
 
Instrumentation and Software 
 
A low-noise potentiostat (Biostat II, Electrochemical and Medical Systems, Newbury, UK) was 
used in all experiments. For CPA experiments, either a Macintosh IIx computer or a Mitac 486 PC was 
used with data acquisition performed using National Instruments (NI, National Instruments Corp., 
Austin, TX, USA) multifunction data acquisition boards:  NB-MIO-16X (Macintosh) and AT-MIO-16 
(PC). Further noise reduction was achieved by averaging 75 (Mac) and 100 (PC) determinations to 
give 1 data point every 2 s. For DPA experiments, all data acquisition was performed on a Mitac 486 
PC with data sampling performed at a rate of 250 determinations/pulse and averaged to give 1 data 
point/pulse [19]. A complete pulse sequence was performed every 2 s. All experiments were 
performed using in house developed software: PC (LabWindows, NI version 2.1); Macintosh 
(LabVIEW, NI version 2.2.1). All analysis was performed using both in house developed software and 
the commercial package Prism (version 4.03, GraphPad Software Inc., CA, USA).  
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The significance of differences observed was estimated using the Student’s t-test for paired 
observations (StatView, Abacus Concepts, Inc., CA, USA). Two-tailed levels of significance were 
used and p < 0.05 was considered to be significant. All data are presented as mean ± S.E.M. 
 
Results and Discussion 
 
Figure 1. Typical raw data examples of the effects of mild hypoxia (A) and hyperoxia (B) on brain 
tissue O2 levels monitored using a carbon paste electrode implanted in the striatum of a freely-moving 
rat. 
 
Hypoxia and Hyperoxia 
 
 We have previously used mild hypoxia and hyperoxia to study brain extracellular glucose 
metabolism in vivo [35]. Both these conditions are ideally suited to investigating and verifying the 
response of CPEs to changes in brain tissue O2 in vivo. A 3-min period of hypoxia caused a decrease in 
the O2 current (∆I) of 27.6 ± 2.8 nA, while a 3-min period of hyperoxia caused an increase in the O2 
current (∆I) of 27.2 ± 4.2 nA, corresponding to mean percentage changes of 57 ± 5% and 43 ± 6% 
respectively (n = 4, see Figure 1A and 1B). Changes in both cases were immediate and on cessation of 
inhalation the signals quickly returned to baseline levels indicating a rapid return to normoxic 
conditions. These results confirmed that CPEs implanted in freely-moving animals respond rapidly to 
changes in cerebral tissue O2 concentrations. 
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Neuronal Activation 
 
Two forms of physiologically stimulated neuronal activation were used; these were tail pinch 
and induced grooming.  In the first, a paper clip was attached ca. 3 cm from the tip of the rat’s tail for 5 
min; this produces a well characterised behaviour pattern which consists of gnawing, licking, eating 
and a general increase in the level of motor activity [36]. In the second, water was dropped from a 
plastic dropper onto the rat's head until the animal engaged in a period (usually between 5 to 10 min) 
of active grooming. 
 
 
 
Figure 2. Typical examples of raw data obtained for the measurement of tissue O2 and blood flow 
(rCBF), monitored simultaneously with bilaterally implanted carbon paste (O2) and Pt/Ir (H2 clearance) 
electrodes in the striatum of a freely-moving rat, in response to behavioral stimulation (5-min tail 
pinch). 
   
The application of a 5 min tail pinch resulted in an immediate and rapid increase in the O2 
current (∆I) recorded at the CPEs by 10.8 ± 1.9 nA from a mean baseline of -200 ± 24 nA (p < 0.001, 
eight tail pinches in two rats). On removal of the stimulus the current immediately began to fall and 
returned to baseline within ca. 10 min. The rCBF, calculated from the H2 clearance at the Pt/Ir 
electrodes, also showed an immediate increase from a basal value of 89 ± 8 mL (100 g)-1 min-1 to a 
maximum of 158 ± 13 mL (100 g)-1 min-1 (p < 0.001), and returned to prestimulus levels ca. 16 min 
after the end of the stimulus. These basal and stimulated flow values are in good agreement with 
previous estimations made in awake animals: basal, 93 mL (100 g)-1 min-1 [37] and 105 mL (100 g)-1 
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min-1 [38]; stimulated, 160 mL (100 g)-1 min-1 [37]. A typical example of the effects of a 5 min tail 
pinch on both O2 and blood flow is shown in Figure 2. 
 
As observed with tail pinch, stimulated grooming (see Figure 3) resulted in an immediate 
increase in striatal O2 levels by 6.2 ± 1.1 nA from a mean baseline of -160 ± 10 nA (p < 0.001, eight 
measurements in two rats). The signal rapidly returned to baseline (typically within 5 min) when the 
animal stopped grooming. Values for rCBF rose from a mean basal level of 81 ± 7 mL (100 g)-1 min-1 
to a maximum of 112 ± 10 mL (100 g)-1 min-1 (p < 0.001). On cessation of activity values also 
returned to basal levels (data not shown) [25].   
 
Figure 3. Typical example of the effect of induced grooming (red bar) on striatal O2 levels monitored 
with an implanted carbon paste electrode and differential pulse amperometry.   
 
The mean percentage increase in rCBF in response to tail pinch was 83 ± 13%, similar to the 
value of 98 ± 16% previously reported for tail pinch by Fellows and Boutelle [37]. The maximum 
percentage increase during induced grooming was 37 ± 4%. Whereas absolute rCBF can be calculated 
from the H2 clearance values, the DPA reduction current at the CPE includes a large background 
signal typical of implanted CPEs. This is due to increased surface wetability resulting from removal of 
the insulating silicone oil by lipids, which constitute approximately 40% of the dry mass of brain tissue 
[19,39]. However, using in vitro calibrations (see Voltammetric Techniques) the increases in O2 for tail 
pinch and grooming were converted to concentrations:  44 ± 8 µmol/L (tail pinch) and 25 ± 4 µmol/L 
(grooming). The O2 concentration in the extracellular fluid (ECF) is a dynamic balance between 
supply of O2 via blood flow in capillaries and O2 consumption associated with metabolism in cells. 
The range measured with implanted microelectrodes is from 5 to 50 µmol/L [18,40].  Assuming a 
maximum ECF concentration of 50 µmol/L the above concentrations represent mean percentage 
increases of 88 ± 15% and 50 ± 9% for tail pinch and grooming respectively.  Although O2 utilization 
increases during stimulated neuronal activity, the present results confirm previous findings that the rise 
in rCBF exceeds the increase in O2 utilization resulting in a net increase in O2 [22,41,42]. For this 
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reason O2 currents provide an index of increases in rCBF only when such increases exceed O2 
utilization [25]. 
 
Saline Injection and Chloral Hydrate Anaesthesia 
 
Figure 4. Typical examples of the effects of intraperitoneal injection of normal saline (A, 0.5 mL, 
NaCl 0.9%) and chloral hydrate (B, 350 mg/kg) on tissue O2 monitored in rat striatum with carbon 
paste electrodes. Arrows indicate the points of injection (A & B), and recovery (B) from the 
anaesthetic. 
 
Chloral hydrate is a commonly used non-volatile anaesthetic agent for animal surgery. It causes 
general CNS depression by rapidly metabolizing into trichloroethanol and trichloroacetic acid [43]. 
Trichloroethanol is suspected to be the active substance for inducing anaesthesia [44] because, similar 
to barbiturates, it has the ability to prolong chloride influx induced by exogenous GABA [45].  
Since the anesthetic was administered by i.p. injection we first examined the effect of i.p. 
injection of normal saline (NaCl 0.9%). A typical example of changes in tissue O2 is shown in Figure 
4A. There was an immediate increase in O2 following injection. The O2 signal (∆I) increased 
maximally by 13.5 ± 3.7 nA at 2.5 ± 0.4 min and had returned to baseline by 4.1 ± 3.7 min (n = 4). 
This increase in current corresponds to an increase in concentration of 50 ± 15 µM based on 
calculations from in vitro calibration curves. Similar initial and brief injection effects have also been 
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observed during the injection of anaesthetic agents, with a comparable return to baseline levels 
occurring before the effect of the anaesthetic takes place and the animal becomes anaesthetized [46]. 
The stress of the i.p. injection stimulates neuronal activation [47], increasing rCBF and thus O2, with 
the supply of the latter exceeding utilization. 
The i.p injection of chloral hydrate produced the same initial response as the i.p. saline 
injection; a brief increase in O2. This was followed by slower more long-lasting changes which 
accompanied the behavioral changes associated with anaesthesia (see Figure 4B). The current (∆I) 
increased to a maximum of 18.7 ± 3.1 nA (p < 0.03, n = 10) at 11.6 ± 1.9 min. This corresponds to an 
increase in concentration of 69 ± 9 µM. The duration of anesthesia, as measured by reflex responses 
(palpebral, corneal and withdrawal reflexes) and spontaneous movements of the rats, was 92 ± 6 min 
(n = 10).  
Several studies have previously been carried out comparing experiments performed in 
conscious and anaesthetized rats indicating significant differences resulting from the effects of the 
different anaesthetics investigated. These have focused on dopamine, DOPAC, 5-HT and HVA and 
have primarily involved the use of microdialysis techniques [44,48-50], although some voltammetric 
studies of dopamine have been made with carbon paste [51] and carbon fiber electrodes [52]. Recently, 
several groups have used in vivo voltammetry with ‘first generation’ amperometric enzyme-based 
biosensors to monitor brain extracellular levels of several non-electroactive analytes under anaesthesia 
in acute experiments [53-66]. A problem which is often overlooked is the effect of anaesthesia on the 
levels of enzymatic mediators, which are intrinsic to the design and operation of these biosensors; 
oxidoreductase enzymes use molecular O2 as a mediator to produce the signal generating H2O2: 
Enzyme/FAD + Substrate → Enzyme/FADH2 + Product 
Enzyme/FADH2 + O2 → Enzyme/FAD + H2O2 
where FAD and FADH2 are the oxidized and reduced states of the redox active prosthetic group, flavin 
adenine dinucleotide. It is clear from this reaction scheme that changing O2 levels can affect accurate 
substrate measurement. Thus, in developing such devices it is important to consider mediator 
interference as well as the direct heterogeneous interference from endogenous electroactive species 
such as ascorbic acid, which has been the traditional focus of interference studies. The findings 
communicated here suggest that caution must be exercised in extrapolating results from acute 
experiments to the conscious state. This is especially true for estimations of basal concentrations, as 
extracellular levels of enzymatic substrates [26] and mediators are clearly altered in a complex manner 
by anaesthesia. 
 
The Effect of Acetazolamide 
 
The carbonic anhydrase inhibitor acetazolamide (Diamox) administered systemically has been shown 
to increase brain pO2 in the ECF [2]. It is an amide derivative belonging to the sulfonamide family and  
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Figure 5. The effects of systemic administration of the carbonic anhydrase inhibitor acetazolamide 
(Diamox, 50 mg/kg, i.p.) on the tissue O2 and blood flow (rCBF) levels monitored simultaneously with 
bilaterally implanted carbon paste (O2) and Pt/Ir (H2 clearance) electrodes in the striatum of a freely-
moving rat. 
 
and by inhibiting carbonic anhydrase reduces HCO3-. The resulting increase in PCO2 is accompanied 
by a pH reduction which causes dilation of cerebral blood vessels. Figure 5 shows the effect of this 
drug (50 mg/kg, i.p.) on the O2 signal and rCBF recorded simultaneously in rat striatum. As expected, 
acetazolamide increased O2 levels in the ECF; the O2 current (∆I) recorded at the CPEs increased by 
43 ± 10 nA. Calibration of the CPEs recovered after the experiments allowed us to estimate the 
increase as 40 ± 12 µM (n = 5, p < 0.03) 10 min after the injection, which is similar to the increase 
observed following mild stress [19]. Values for rCBF rose from a mean basal level of 118 ± 4 mL (100 
g)-1 min-1 to a maximum of 182 ± 2 mL (100 g)-1 min-1 (p < 0.001). These results confirm that 
acetazolamide increases brain tissue O2 levels through an increase in rCBF. This increase would 
appear to be sustained for a prolonged period after administration (see Figure 5). Such characteristics 
make this drug ideally suited for testing the in vivo O2 sensitivity of ‘first generation’ amperometric 
enzyme-based biosensors [67]. 
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Conclusions 
 
Mild hypoxia and hyperoxia produced rapid changes (decrease and increase respectively) in the 
in vivo O2 signal confirming that CPEs implanted in freely-moving animals respond rapidly to changes 
in cerebral tissue O2 concentrations. Neuronal activation (tail pinch and stimulated grooming) 
produced similar increases in both O2 and rCBF indicating that CPE O2 currents provide an index of 
increases in rCBF when such increases exceed O2 utilization. Saline injection produced a transient 
increase in the O2 signal while chloral hydrate produced slower more long-lasting changes that 
accompanied the behavioral changes associated with anesthesia. Acetazolamide increased O2 levels 
through an increase in rCBF. While the latter confirms that acetazolamide is ideally suited for testing 
the in vivo O2 sensitivity of ‘first generation’ amperometric enzyme-based biosensors, the former 
suggests that caution must be exercised in extrapolating results from acute experiments to the 
conscious state. 
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